|
Post by sayhey24 on Aug 7, 2017 17:53:06 GMT -5
I didn't like that tongue twist comment regarding finance vs short term needs. Should have restated it. To me it seemed like he might have been intending to say that their financing efforts might not arrive in time to meet the short term cash needs. So if that wasn't it, would be good to clarify, and if it was it... still should have simply restated it clearly for transparency. Does anyone actually recall specific wording? What he said was they had enough money to meet current needs to take then into the beginning of 2018 and that he wasn't losing any sleep as they had various options.
|
|
|
Post by dreamboatcruise on Aug 7, 2017 17:55:44 GMT -5
I didn't like that tongue twist comment regarding finance vs short term needs. Should have restated it. To me it seemed like he might have been intending to say that their financing efforts might not arrive in time to meet the short term cash needs. So if that wasn't it, would be good to clarify, and if it was it... still should have simply restated it clearly for transparency. Does anyone actually recall specific wording? What he said was they had enough money to meet current needs to take then into the beginning of 2018 and that he wasn't losing any sleep as they had various options. Eeeeeeh... dementia setting in. Not good in an exec. Bet the transcript proves you wrong though.
|
|
|
Post by promann on Aug 7, 2017 17:57:33 GMT -5
You're on to something... and they specifically didn't talk about Amgen, or Google, or Apple, or Amazon... it's mind blowing what all that "not saying" must mean. Good Grief - give these guys a break. In the 10 years I have heard these calls this was the first profession call I ever listened to from MNKD. They also did not say what "category" they asked for on the label - "ultra" maybe maybe something else. I never like being associated with the analogs. "Ultra" keeps it too close to the analogs. I am not sure what Amgen would bring to the party except a low ball buy-out. Amazon, well whats this subscription service? Dachis at the ASM was the one talking about Amazon. Google - well we know they took $100M from Dexcom and another $250M from SNY. If they want to apply the Tech with Ondou which Mike was discussing and address meal time spikes, there are not many choices out there. In fact there is only one. And Apple, Tim Cook clearly wants to play in the non-FDA CGM market and is looking to get the IWatch CGM out in 2018. Sayhey I saw a Dexcom Comercial on CNN last night sporting the I watch and IPhone I'm surprised there is no new topic about it yet has anyone else seen the commercial?
|
|
|
Post by celo on Aug 7, 2017 17:59:55 GMT -5
Nice, but without articulating those options, it doesn't allow investors any confidence after the second quarter results. There really should of been some expression of what options are on the table to increase the runway another 4 months after september.
|
|
|
Post by sayhey24 on Aug 7, 2017 18:07:31 GMT -5
Good Grief - give these guys a break. In the 10 years I have heard these calls this was the first profession call I ever listened to from MNKD. They also did not say what "category" they asked for on the label - "ultra" maybe maybe something else. I never like being associated with the analogs. "Ultra" keeps it too close to the analogs. I am not sure what Amgen would bring to the party except a low ball buy-out. Amazon, well whats this subscription service? Dachis at the ASM was the one talking about Amazon. Google - well we know they took $100M from Dexcom and another $250M from SNY. If they want to apply the Tech with Ondou which Mike was discussing and address meal time spikes, there are not many choices out there. In fact there is only one. And Apple, Tim Cook clearly wants to play in the non-FDA CGM market and is looking to get the IWatch CGM out in 2018. Sayhey I saw a Dexcom Comercial on CNN last night sporting the I watch and IPhone I'm surprised there is no new topic about it yet has anyone else seen the commercial? It was discussed last month when Apple was holding their tech conference. Mike mentioned Dexcom, Abbott Libre and One-Drop on the call. The more Tech the better for MNKD because technology was afrezza's only hope to save it and it looks like it is getting here just in time. Once people start getting immediate feedback they will want to manage their meal time spikes and there is no hiding from the BG numbers. Doctors can no-longer say come back next month when the PWD walks in the office with the Libre profile from the last month and says that metformin is junk, I need afrezza. Or better yet, logs into the One-Drop site at the doctors office and says look at the mess metformin is making and my One-Drop coaches say I need afrezza.
|
|
|
Post by wgreystone on Aug 7, 2017 18:18:50 GMT -5
Given that the plant is pledged as collateral to Deerfield, I wouldn't get my hopes up. Thanks... I got too excited and wasn't remembering that. Lizards are easily excited by management dangling shining objects in front of them. That answers the question "why hasn't this been brought up before?". [Edit] Bad management (insert rolled up newspaper emoticon here) They could sell the Danbury plant to Amphastar and use Amphastar as contract manufacturer.
|
|
|
Post by mnkdfann on Aug 7, 2017 18:26:36 GMT -5
Those shares won't be free, either. It's not like they can just steal shares from equity holders - the equity holders still own the shares, TASE or not. I do not think there is any possibility they are taking shares from equity holders. I think the idea is that delisting from TASE somehow frees shares can be sold. Over at SA, one of the comment posters suggested that possibly "they couldn't issue the 10 million authorized preferred shares on the balance sheet ahead of the common while listed on TASE". See comment section of this article seekingalpha.com/article/4095774-mannkind-afrezza-scripts-dip
|
|
|
Post by sayhey24 on Aug 7, 2017 18:27:47 GMT -5
Thanks... I got too excited and wasn't remembering that. Lizards are easily excited by management dangling shining objects in front of them. That answers the question "why hasn't this been brought up before?". [Edit] Bad management (insert rolled up newspaper emoticon here) They could sell the Danbury plant to Amphastar and use Amphastar as contract manufacturer. I am thinking bigger than Amphastar. There is this guy who always admired Al Mann and what Al did and it seems like he knows something about real estate and insurance. Maybe he could spare a dime bloomberg.com/news/articles/2017-08-07/buffett-nears-a-milestone-he-doesn-t-want-100-billion-in-cash
|
|
|
Post by mnkdfann on Aug 7, 2017 18:29:03 GMT -5
Buffet is the new Amgen.
|
|
|
Post by therealisaching on Aug 7, 2017 18:33:47 GMT -5
Those shares won't be free, either. It's not like they can just steal shares from equity holders - the equity holders still own the shares, TASE or not. I do not think there is any possibility they are taking shares from equity holders. I think the idea is that delisting from TASE somehow frees shares can be sold. Over at SA, one of the comment posters suggested that possibly "they couldn't issue the 10 million authorized preferred shares on the balance sheet ahead of the common while listed on TASE". See comment section of this article seekingalpha.com/article/4095774-mannkind-afrezza-scripts-dipMike mentioned on the call that delisting from the tase opens the possibility of the preferred shares. The 10q states the tase shares will trade on the Nasdaq once the delisting is final
|
|
|
Post by dreamboatcruise on Aug 7, 2017 18:33:59 GMT -5
They could sell the Danbury plant to Amphastar and use Amphastar as contract manufacturer. I am thinking bigger than Amphastar. There is this guy who always admired Al Mann and what Al did and it seems like he knows something about real estate and insurance. Maybe he could spare a dime bloomberg.com/news/articles/2017-08-07/buffett-nears-a-milestone-he-doesn-t-want-100-billion-in-cash If only he knew something about investing in companies and just did that with MNKD. Too bad Deerfield has Danbury as collateral if Buffet only knows how to do real estate deals. But this is highly likely given that MNKD hasn't mentioned it... sometimes saying nothing says a lot.
|
|
|
Post by derek2 on Aug 7, 2017 18:37:34 GMT -5
I do not think there is any possibility they are taking shares from equity holders. I think the idea is that delisting from TASE somehow frees shares can be sold. Over at SA, one of the comment posters suggested that possibly "they couldn't issue the 10 million authorized preferred shares on the balance sheet ahead of the common while listed on TASE". See comment section of this article seekingalpha.com/article/4095774-mannkind-afrezza-scripts-dipMike mentioned on the call that delisting from the tase opens the possibility of the preferred shares. The 10q states the tase shares will trade on the Nasdaq once the delisting is final Thanks to both of you for the clarification!
|
|
|
Post by agedhippie on Aug 7, 2017 18:39:33 GMT -5
Those shares won't be free, either. It's not like they can just steal shares from equity holders - the equity holders still own the shares, TASE or not. I do not think there is any possibility they are taking shares from equity holders. I think the idea is that delisting from TASE somehow frees shares can be sold. Over at SA, one of the comment posters suggested that possibly "they couldn't issue the 10 million authorized preferred shares on the balance sheet ahead of the common while listed on TASE". See comment section of this article seekingalpha.com/article/4095774-mannkind-afrezza-scripts-dipThe prefs were approved as part of the reverse split so they are already on the shelf to be issued. The previous 10K had them listed under the risks section ("likely have superior rights, preferences and privileges to those of our common stock") as does this 10Q. The prefs are a last resort because of that superiority.
|
|
|
Post by peppy on Aug 7, 2017 18:41:24 GMT -5
Mike mentioned on the call that delisting from the tase opens the possibility of the preferred shares. The 10q states the tase shares will trade on the Nasdaq once the delisting is final Thanks to both of you for the clarification! there is that TASE lawsuit.
on another note, the replay is not up on the Mannkind Website yet. grrr.
|
|
|
Post by sayhey24 on Aug 7, 2017 18:45:19 GMT -5
I am thinking bigger than Amphastar. There is this guy who always admired Al Mann and what Al did and it seems like he knows something about real estate and insurance. Maybe he could spare a dime bloomberg.com/news/articles/2017-08-07/buffett-nears-a-milestone-he-doesn-t-want-100-billion-in-cash If only he knew something about investing in companies and just did that with MNKD. Too bad Deerfield has Danbury as collateral if Buffet only knows how to do real estate deals. But this is highly likely given that MNKD hasn't mentioned it... sometimes saying nothing says a lot. Only a white knight looking to do something good for humanity would give MNKD the $200M they put into the plant. At the same time getting in on the greatest advance in diabetes care in 95 years probably has Buffet's attention. I think Mike can make that elevator pitch. Its like peanut butter and jelly. Buffet's got $100B he needs to do something with and MNKD needs a couple hundred $Million. Mike would be doing Buffet the favor by giving him this opportunity.
|
|